The association of interleukin-1α and interleukin-1β polymorphisms with the risk of Graves' disease in a case-control study and meta-analysis

Human Immunology

Volumn 71, Issue 4, 2010, Pages 397-401

  Liu, Nan ^a   Li, Xuejun ^b   Liu, Changqin ^b   Zhao, Yongju ^a   Cui, Bin ^a   Ning, Guang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

Graves' disease; IL 1 ; IL 1 ; Meta analysis; Polymorphism

Indexed keywords

INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA;

ADOLESCENT; ADULT; AGED; ARTICLE; ASIAN; CASE CONTROL STUDY; CHILD; CHINESE; CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; GRAVES DISEASE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; POPULATION RESEARCH; PRIORITY JOURNAL; ENDOCRINE OPHTHALMOPATHY; GENETIC PREDISPOSITION; GENETICS; IRAN; MIDDLE AGED; PATHOPHYSIOLOGY; POLAND; RISK FACTOR; TAIWAN;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GRAVES DISEASE; GRAVES OPHTHALMOPATHY; HUMANS; INTERLEUKIN-1ALPHA; INTERLEUKIN-1BETA; IRAN; MALE; MIDDLE AGED; POLAND; POLYMORPHISM, GENETIC; RISK FACTORS; TAIWAN;

EID: 77950545195     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2010.01.023     Document Type: Article

References (35)

1. Chen X., Wu W.S., Chen G.L., Zhang K.Z., Zhang F.L., Lin Y.C., et al. The effect of salt iodization for 10 years on the prevalences of endemic goiter and hyperthyroidism. Chin J Endocrinol Metab 2000, 18:342-344.
2. Weetman A.P. Graves' disease. N Engl J Med 2000, 343:1236-1248.
3. Tomer Y., Davies T.F. Searching for the autoimmune thyroid disease susceptibility genes: From gene mapping to gene function. Endocr Rev 2003, 24:694-717.
4. Onodera T., Awaya A. Anti-thyroglobulin antibodies induced with recombinant reovirus infection in BALB/c mice. Immunology 1990, 71:581-585.
5. Simmonds M.J., Howson J.M., Heward J.M., Cordell H.J., Foxall H., Carr-Smith J., et al. Regression mapping of association between the human leukocyte antigen region and Graves' disease. Am J Hum Genet 2005, 76:157-163.
6. Han S., Zhang S., Zhang W., Li R., Li Y., Wang Z., et al. CTLA4 polymorphisms and ophthalmopathy in Graves' disease patients: Association study and meta-analysis. Hum Immunol 2006, 67:618-626.
7. Tomer Y., Concepcion E., Greenberg D.A. A C/T single-nucleotide polymorphism in the region of the CD40 gene is associated with Graves' disease. Thyroid 2002, 12:1129-1135.
8. Velaga M.R., Wilson V., Jennings C.E., Owen C.J., Herington S., Donaldson P.T., et al. The codon 620 tryptophan allele of the lymphoid tyrosine phosphatase (LYP) gene is a major determinant of Graves' disease. J Clin Endocrinol Metab 2004, 89:5862-5865.
9. Hiratani H., Bowden D.W., Ikegami S., Shirasawa S., Shimizu A., Iwatan Y., et al. Multiple SNPs in intron 7 of thyrotropin receptor are associated with Graves' disease. J Clin Endocrinol Metab 2005, 90:2898-2903.
10. Busfield S.J., Comrack C.A., Yu G., Chickering T.W., Smutko J.S., Zhou H., et al. Identification and gene organization of three novel members of the IL-1 family on human chromosome 2. Genomics 2000, 66:213-216.
11. Rasmussen A.K., Bendtzen K., Feldt-Rasmussen U. Thyrocyte-interleukin-1 interactions. Exp Clin Endocrinol Diabetes 2000, 108:67-71.
12. Oberholzer A., Oberholzer C., Moldawer L.L. Cytokine signaling-regulation of the immune response in normal and critically ill states. Crit Care Med 2000, 28:3-12.
13. Bahn R.S. Pathophysiology of Graves' ophthalmopathy: The cycle of disease [Review]. J Clin Endocrinol Metab 2003, 88:1939-1946.
14. Phenekos C., Vryonidou A., Gritzapis A.D., Baxevanis C.N., Goula M., Papamichail M. Th1 and Th2 serum cytokine profiles characterize patients with Hashimoto's thyroiditis (Th1) and Graves' disease (Th2). Neuroimmunomodulation 2004, 11:209-213.
15. Khalilzadeh O., Anvari M., Esteghamati A., Mahmoudi M., Tahvildari M., Rashidi A., et al. Graves' ophthalmopathy and gene polymorphisms in interleukin-1alpha, interleukin-1beta, interleukin-1 receptor and interleukin-1 receptor antagonist. Clin Experiment Ophthalmol 2009, 37:614-619.
16. Chen R.H., Chen W.C., Chang C.T., Tsai C.H., Tsai F.J. Interleukin-1-beta gene, but not the interleukin-1 receptor antagonist gene, is associated with Graves' disease. J Clin Lab Anal 2005, 19:133-138.
17. Lacka K., Paradowska A., Gasinska T., Soszynska J., Wichary H., Kramer L., et al. Interleukin-1beta gene (IL-1beta) polymorphisms (SNP -511 and SNP +3953) in thyroid-associated ophthalmopathy (TAO) among the Polish population. Curr Eye Res 2009, 34:215-220.
18. Hunt P.J., Marshall S.E., Weetman A.P., Bell J.I., Wass J.A., Welsh K.I. Cytokine gene polymorphisms in autoimmune thyroid disease. J Clin Endocrinol Metab 2000, 85:1984-1988.
19. Werner S.C. Modification of the classification of the eye changes of Graves' disease: Recommendations of the Ad Hoc Committee of the American Thyroid Association. J Clin Endocrinol Metab 1977, 44:203-204.
20. Solé X., Guinó E., Valls J., Iniesta R., Moreno V. SNPStats: A web tool for the analysis of association studies. Bioinformatics 2006, 22:1928-1929.
21. Higgins J.P., Thompson S.G., Deeks J.J., Altman D.G. Measuring inconsistency in meta-analyses [Review]. BMJ 2003, 327:557-560.
22. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986, 7:177-188.
23. Gianoukakis A.G., Khadavi N., Smith T.J. Cytokines, Graves' disease, and thyroid-associated ophthalmopathy. Thyroid 2008, 18:953-958.
24. Gianoukakis A.G., Jennings T.A., King C.S., Sheehan C.E., Hoa N., Heldin P., et al. Hyaluronan accumulation in thyroid tissue: Evidence for contributions from epithelial cells and fibroblasts. Endocrinology 2007, 148:54-62.
25. Naik V., Khadavi N., Naik M.N., Hwang C., Goldberg R.A., Tsirbas A., et al. Biologic therapeutics in thyroid-associated ophthalmopathy: Translating disease mechanism into therapy. Thyroid 2008, 18:967-971.
26. Bicek A., Zaletel K., Gaberscek S., Pirnat E., Krhin B., Stopar T.G., et al. 49A/G and CT60 polymorphisms of the cytotoxic T-lymphocyte-associated antigen 4 gene associated with autoimmune thyroid disease. Hum Immunol 2009, 70:820-824.
27. Kammoun-Krichen M., Bougacha-Elleuch N., Makni K., Rebai M., Peraldi-Roux S., Rebai A., et al. Association analysis of interleukin gene polymorphisms in autoimmune thyroid diseases in the Tunisian population. Eur Cytokine Netw 2007, 18:196-200.
28. Beretta L., Cappiello F., Moore J.H., Scorza R. Interleukin-1 gene complex single nucleotide polymorphisms in systemic sclerosis: A further step ahead. Hum Immunol 2008, 69:187-192.
29. Cullup H., Dickinson A.M., Cavet J., Jackson G.H., Middleton P.G. Polymorphisms of interleukin-1alpha constitute independent risk factors for chronic graft-versus-host disease after allogeneic bone marrow transplantation. Br J Haematol 2003, 122:778-787.
30. Ravaglia G., Paola F., Maioli F., Martelli M., Montesi F., Bastagli L., et al. Interleukin-1beta and interleukin-6 gene polymorphisms as risk factors for AD: A prospective study. Exp Gerontol 2006, 41:85-92.
31. Muraki Y., Tsutsumi A., Takahashi R., Suzuki E., Hayashi T., Chino Y., et al. Polymorphisms of IL-1 beta gene in Japanese patients with Sjögren's syndrome and systemic lupus erythematosus. J Rheumatol 2004, 31:720-725.
32. Rainero I., Bo M., Ferrero M., Valfrè W., Vaula G., Pinessi L. Association between the interleukin-1alpha gene and Alzheimer's disease: A meta-analysis. Neurobiol Aging 2004, 25:1293-1298.
33. Lee Y.H., Ji J.D., Song G.G. Association between interleukin 1 polymorphisms and rheumatoid arthritis susceptibility: A meta-analysis. J Rheumatol 2009, 36:12-15.
34. Vincenzi B., Patti G., Galluzzo S., Pantano F., Venditti O., Santini D., et al. Interleukin 1beta-511T gene (IL1beta) polymorphism is correlated with gastric cancer in the Caucasian population: Results from a meta-analysis. Oncol Rep 2008, 20:1213-1220.
35. Harrison P., Pointon J.J., Chapman K., Roddam A., Wordsworth B.P. Interleukin-1 promoter region polymorphism role in rheumatoid arthritis: A meta-analysis of IL-1B-511A/G variant reveals association with rheumatoid arthritis. Rheumatology (Oxford) 2008, 47:1768-1770.